skip to Main Content

Candidate Nomination

In this phase we characterize the most promising leads from the lead optimization phase with the aim of producing a data package ready to submit for investigational new drug (ind). Approaches we use include:

  • Full characterization of compounds for promotionto development
  • Focused ADME around a specific dosage form
  • Early toxicity studies including genotoxicity and carcinogenicity
Back To Top